Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Behavioral Neuroscience
|
January 5, 2002
Spared discrimination and impaired reversal eyeblink conditioning in patients with temporal lobe amnesia
M C Carrillo, J D Gabrieli, R O Hopkins, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 15, 1996
Functional mapping of human learning: a positron emission tomography activation study of eyeblink conditioning
T A Blaxton, T A Zeffiro, J D Gabrieli, et al.
Experimental Gerontology
|
February 28, 2001
Involvement of mu class glutathione S-transferase subunit M2 (rGST M2) levels in the initiation and promotion of hepatocellular carcinogenesis in old rats
M C Carrillo, C Favre, C E Carnovale, et al.
Neurology
|
October 27, 2004
Altered cortical visual processing in PD with hallucinations: an fMRI study
G T Stebbins, C G Goetz, M C Carrillo, et al.
Medicina
|
June 13, 2002
[In vivo apoptotic effect of alpha-2b interferon (IFN) on rat preneoplastic liver ]
M L Alvarez, J P Cerliani, J A Monti, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force
P S Aisen, E Siemers, D Michelson, et al.
The Journal of Nutrition, Health & Aging
|
December 1, 2017
Editorial: Collaborative Efforts to Prevent Alzheimer's Disease
J Touchon, J Rosenbaum, P Aisen, et al.
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
D Angioni, O Hansson, R J Bateman, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force
D Angioni, J Cummings, C J Lansdall, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial Populations
B Vellas, C Sampaio, R Bateman, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Behavioral Neuroscience
|
January 5, 2002
Spared discrimination and impaired reversal eyeblink conditioning in patients with temporal lobe amnesia
M C Carrillo, J D Gabrieli, R O Hopkins, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 15, 1996
Functional mapping of human learning: a positron emission tomography activation study of eyeblink conditioning
T A Blaxton, T A Zeffiro, J D Gabrieli, et al.
Experimental Gerontology
|
February 28, 2001
Involvement of mu class glutathione S-transferase subunit M2 (rGST M2) levels in the initiation and promotion of hepatocellular carcinogenesis in old rats
M C Carrillo, C Favre, C E Carnovale, et al.
Neurology
|
October 27, 2004
Altered cortical visual processing in PD with hallucinations: an fMRI study
G T Stebbins, C G Goetz, M C Carrillo, et al.
Medicina
|
June 13, 2002
[In vivo apoptotic effect of alpha-2b interferon (IFN) on rat preneoplastic liver ]
M L Alvarez, J P Cerliani, J A Monti, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force
P S Aisen, E Siemers, D Michelson, et al.
The Journal of Nutrition, Health & Aging
|
December 1, 2017
Editorial: Collaborative Efforts to Prevent Alzheimer's Disease
J Touchon, J Rosenbaum, P Aisen, et al.
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
D Angioni, O Hansson, R J Bateman, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force
D Angioni, J Cummings, C J Lansdall, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 20, 2017
EU./U.S. CTAD Task Force on Alzheimer's Trial Populations
B Vellas, C Sampaio, R Bateman, et al.
Page
of 7